Want to see SE:INIT full AI Analyst Report?
Initiator Pharma A/S (INIT) Ratios
0 Followers
Initiator Pharma A/S Ratios
SE:INIT's free cash flow for Q2 2026 was kr-5.02M. For the 2026 fiscal year, SE:INIT's free cash flow was increased by kr0.00 and operating cash flow was kr-5.02M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 25.77 | 29.95 | 9.34 | 27.70 | 9.91 |
| Quick Ratio | 25.77 | 29.95 | 9.34 | 27.70 | 9.91 |
| Cash Ratio | 20.52 | 26.22 | 7.57 | 22.30 | 6.30 |
| Solvency Ratio | -4.08 | -0.03 | -0.00 | -2.69 | -1.13 |
| Operating Cash Flow Ratio | -14.21 | -23.69 | -5.54 | -18.74 | -6.29 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | kr 29.54M | kr 14.77M | kr 11.14M | kr 34.01M | kr 34.99M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.00 | 0.52 | 0.26 | 0.25 |
| Debt-to-Equity Ratio | 0.07 | 0.00 | 1.38 | 0.37 | 0.38 |
| Debt-to-Capital Ratio | 0.07 | 0.00 | 0.58 | 0.27 | 0.28 |
| Long-Term Debt-to-Capital Ratio | 0.07 | 0.00 | 0.58 | 0.27 | 0.28 |
| Financial Leverage Ratio | 1.12 | 1.03 | 2.67 | 1.42 | 1.53 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | -0.02 | -0.02 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -0.02 | -0.02 |
| Debt to Market Cap | 0.02 | 0.00 | 0.05 | 64.73 | 64.45 |
| Interest Debt Per Share | 0.03 | 0.00 | 0.29 | 309.76 | 412.16 |
| Net Debt to EBITDA | 1.32 | 922.14 | 321.84 | 631.10 | 904.38 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 81.98% | 87.17% | 82.56% | 87136.32% | 86883.35% |
| EBT Per EBIT | 93.90% | 102.30% | 102.50% | 105.73% | 105.08% |
| Return on Assets (ROA) | -42.47% | -0.08% | -0.08% | -79.54% | -39.22% |
| Return on Equity (ROE) | -47.39% | -0.09% | -0.20% | -113.03% | -60.19% |
| Return on Capital Employed (ROCE) | -57.40% | -0.10% | -0.10% | -0.09% | -0.05% |
| Return on Invested Capital (ROIC) | -47.05% | -0.09% | -0.08% | -0.08% | -0.04% |
| Return on Tangible Assets | -42.47% | -0.08% | -0.08% | -79.54% | -39.22% |
| Earnings Yield | -11.01% | -5.22% | -0.01% | -19790.69% | -10215.57% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 17.15 | 0.03 | 0.06 | 0.05 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -21.28 | -12064.48 | -6345.25 | -7608.72 | -81013.59 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 21.28 | 12064.48 | 6345.25 | 7608.72 | 81013.59 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.29 | -217.17 | -0.34 | -676.69 | -971.76 |
| Free Cash Flow Per Share | -0.28 | -217.17 | -0.34 | -676.69 | -971.76 |
| Dividend Paid and CapEx Coverage Ratio | -1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | -1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | -8.46 | 0.00 | -1.14 | -2.60 | -2.57 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -13.93% | -4874.54% | -5.46% | -16829.42% | -16536.29% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -8.88 | -19.37 | -14143.24 | -0.01 | -0.01 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 4.31 | 0.02 | 28.98 | 0.01 | 0.01 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -7.18 | -0.02 | -18.33 | -0.01 | -0.01 |
| Price-to-Operating Cash Flow Ratio | -7.00 | -0.02 | -18.33 | -0.01 | -0.01 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.00 | 141.50 | -0.00 | -0.00 |
| Enterprise Value Multiple | -5.67 | 905.05 | -11646.73 | 626.44 | 895.44 |
| Enterprise Value | 103.16M | -13.12M | 314.80M | -26.14M | -20.65M |
| EV to EBITDA | -5.67 | 905.05 | -11646.73 | 626.44 | 895.44 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -5.82 | 1.09 | -17.84 | 0.80 | 0.61 |
| EV to Operating Cash Flow | -5.67 | 1.09 | -17.84 | 0.80 | 0.61 |
| Tangible Book Value Per Share | 0.47 | 265.75 | 0.21 | 704.05 | 997.32 |
| Shareholders’ Equity Per Share | 0.47 | 265.75 | 0.21 | 704.05 | 997.32 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.18 | 0.13 | 0.17 | 0.13 | 0.13 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.22 | -0.23 | -0.00 | -795.76 | -600.32 |
| Tax Burden | 0.82 | 0.87 | 0.83 | 871.36 | 868.83 |
| Interest Burden | 0.94 | 1.02 | 1.03 | 1.06 | 1.05 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.30 | 0.81 | 0.77 | 0.74 | 1.41 |
Currency in DKK
